These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 6239414

  • 21. Mechanisms of immunologic unresponsiveness induced by ultraviolet-irradiated donor-specific blood transfusions and peritransplant cyclosporine.
    Oluwole SF, Chabot J, Pepino P, Reemtsma K, Hardy MA.
    Transplantation; 1988 Sep; 46(3):352-8. PubMed ID: 2971279
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome.
    Christiaans MH, van Hooff JP, Nieman F, van den Berg-Loonen EM.
    Transplantation; 1999 Apr 15; 67(7):1029-35. PubMed ID: 10221489
    [Abstract] [Full Text] [Related]

  • 24. Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy.
    Knight RJ, Kerman RH, Welsh M, Golden D, Schoenberg L, Van Buren CT, Lewis RM, Kahan BD.
    Transplantation; 1991 Feb 15; 51(2):355-9. PubMed ID: 1994527
    [Abstract] [Full Text] [Related]

  • 25. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
    Kerman RH, van Buren CT, Lewis RM, Frazier OH, Cooley D, Kahan BD.
    Transplantation; 1988 Feb 15; 45(2):333-7. PubMed ID: 3278425
    [Abstract] [Full Text] [Related]

  • 26. Clinical aspects of sensitization.
    Katznelson S, Bhaduri S, Cecka JM.
    Clin Transpl; 1997 Feb 15; ():285-96. PubMed ID: 9919412
    [Abstract] [Full Text] [Related]

  • 27. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients.
    Barber WH, Mankin JA, Laskow DA, Deierhoi MH, Julian BA, Curtis JJ, Diethelm AG.
    Transplantation; 1991 Jan 15; 51(1):70-5. PubMed ID: 1987708
    [Abstract] [Full Text] [Related]

  • 28. Optimization of donor specific blood transfusion in kidney transplantation.
    Cheigh JS, Suthanthiran M, Stubenbord WT, Fotino M, Riggio RR, Schechter N, Stenzel KH, Rubin AL.
    Transplant Proc; 1987 Feb 15; 19(1 Pt 3):2250-1. PubMed ID: 2978891
    [Abstract] [Full Text] [Related]

  • 29. Improved results of cadaver renal transplantation with azathioprine, prednisone and antilymphoblast globulin.
    Novick AC, Khauli RB, Braun WE, Steinmuller D, Cunningham R, Buszta C, Goormastic M.
    J Urol; 1984 Apr 15; 131(4):636-40. PubMed ID: 6368866
    [Abstract] [Full Text] [Related]

  • 30. Significant reduction of sensitization and improved allograft outcome with donor-specific buffy coat transfusion.
    Okazaki H, Takahashi H, Miura K, Ishizaki M, Taguchi Y.
    Transplantation; 1984 May 15; 37(5):523-5. PubMed ID: 6233767
    [No Abstract] [Full Text] [Related]

  • 31. Incidental and purposeful random donor blood transfusion. Sensitization and transplantation.
    Pfaff WW, Howard RJ, Scornik JC, Day C, Renderer J, Scott J, Fennel RS, Peterson JC, Salomon DR, Patton PR.
    Transplantation; 1989 Jan 15; 47(1):130-3. PubMed ID: 2643223
    [Abstract] [Full Text] [Related]

  • 32. Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients.
    Itescu S, Burke E, Lietz K, John R, Mancini D, Michler R, Rose E, Oz M, Edwards N.
    Circulation; 2002 Mar 12; 105(10):1214-9. PubMed ID: 11889016
    [Abstract] [Full Text] [Related]

  • 33. The mechanism of the induction of immunologic unresponsiveness to rat cardiac allografts by recipient pretreatment with donor lymphocyte subsets.
    Oluwole SF, Ng AK, Reemtsma K, Hardy MA.
    Transplantation; 1989 Aug 12; 48(2):281-8. PubMed ID: 2526971
    [Abstract] [Full Text] [Related]

  • 34. The use of cyclosporine in living-related renal transplantation. Donor-specific hyporesponsiveness and steroid withdrawal.
    Flechner SM, Kerman RH, Van Buren CT, Epps L, Kahan BD.
    Transplantation; 1984 Dec 12; 38(6):685-91. PubMed ID: 6239415
    [Abstract] [Full Text] [Related]

  • 35. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ, West-Thielke PM, Herren HL, Bareato U, Ommert T, Vidanovic V, Campbell-Lee SA, Tzvetanov IG, Sankary HN, Kaplan B, Benedetti E, Oberholzer J.
    Transplantation; 2009 Jan 27; 87(2):268-73. PubMed ID: 19155983
    [Abstract] [Full Text] [Related]

  • 36. Induction of immune alterations and successful renal transplantation with a simplified method of donor-specific blood transfusion.
    Cheigh JS, Suthanthiran M, Kaplan M, Evelyn M, Riggio RR, Fotino M, Schechter N, Wolf CF, Stubenbord WT, Stenzel KH.
    Transplantation; 1984 Nov 27; 38(5):501-6. PubMed ID: 6238460
    [Abstract] [Full Text] [Related]

  • 37. Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.
    van der Mast BJ, van Besouw NM, de Kuiper P, Vaessen LM, Gregoor PJ, IJzermans JN, van Gelder T, Claas FH, Weimar W.
    Transplantation; 2001 Sep 15; 72(5):873-80. PubMed ID: 11571453
    [Abstract] [Full Text] [Related]

  • 38. Improved allograft survival in nonidentical living related donor transplants using donor-specific blood transfusions.
    Mendez R, Mendez RG, Iwaki YI, Kinukawa T, Bogaard TP, Self BA, Terasaki PI.
    J Urol; 1985 Mar 15; 133(3):383-5. PubMed ID: 3973987
    [Abstract] [Full Text] [Related]

  • 39. Improved renal allograft survival following donor-specific transfusions. III. Kinetics of mixed lymphocyte culture responses before and after transplantation.
    Burlingham WJ, Grailer A, Sondel PM, Sollinger HW.
    Transplantation; 1988 Jan 15; 45(1):127-32. PubMed ID: 2962347
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.